BOT 0.67% 37.8¢ botanix pharmaceuticals ltd

Yes it's good to temper expectations a bit, only 65% of...

  1. 204 Posts.
    lightbulb Created with Sketch. 33
    Yes it's good to temper expectations a bit, only 65% of Americans have health insurance so the potential market is more like double the size of Japan not triple.
    Also I recall a video of Matt or Howie saying that they think the insurance companies would likely only pay $540 so Bot will probably only charge $540 so there's no gap payment for consumers.
    Another concern is the delay from the relabeling will have allowed people to try qbrexa and more than 40% of them will have experienced zero side effects so they are unlikely to change products if they are having success with the competition.
    That said at $6000 per year per person 50,000 patients will bring in 300million $ so there is still amazing possibility for huge profits here. Aimo
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
37.8¢
Change
0.003(0.67%)
Mkt cap ! $559.1M
Open High Low Value Volume
37.0¢ 38.0¢ 35.5¢ $3.180M 8.692M

Buyers (Bids)

No. Vol. Price($)
7 145132 37.5¢
 

Sellers (Offers)

Price($) Vol. No.
38.0¢ 534353 16
View Market Depth
Last trade - 12.56pm 25/06/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.